Showing 541 - 560 results of 1,793 for search '"HIV"', query time: 0.09s Refine Results
  1. 541
  2. 542
  3. 543

    Mathematical Analysis of the Role of Treatment and Vaccination in the Management of the HIV/AIDS and Pneumococcal Pneumonia Co-Infection by Michael Byamukama, Martin Karuhanga, Damian Kajunguri

    Published 2025-01-01
    “…Concomitant infections by two or more pathogens are on upsurge and among these is the interplay between HIV/AIDS and pneumococcal pneumonia infections. …”
    Get full text
    Article
  4. 544

    Factors Influencing Survival Status of HIV/AIDS after HAART in Huzhou City, Eastern China by Meihua Jin, Zhongrong Yang, Jing Li, Xiaoqi Liu, Zhenqian Wu

    Published 2022-01-01
    “…Highly active antiretroviral therapy (HAART) can effectively reduce the risk of death and opportunistic infections in patients with HIV/AIDS. The aim of this study was to analyse the survival status and its influencing factors in HIV/AIDS after HAART. …”
    Get full text
    Article
  5. 545
  6. 546

    Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review by Robert Root-Bernstein

    Published 2024-08-01
    “…Thus, non-HIV infections are as important to understanding susceptibility to HIV infection, its progression, and the effectiveness of treatments and prevention. …”
    Get full text
    Article
  7. 547

    CD4 Count Pattern and Demographic Distribution of Treatment-Naïve HIV Patients in Lagos, Nigeria by Akinsegun Akinbami, Adedoyin Dosunmu, Adewumi Adediran, Sarah Ajibola, Olajumoke Oshinaike, Kikelomo Wright, Olanrewaju Arogundade

    Published 2012-01-01
    “…Using the CD4 count, this study aimed at determining the percentage of HIV-positives who require antiretroviral therapy at enrollment in an HIV treatment and care centre. …”
    Get full text
    Article
  8. 548
  9. 549
  10. 550
  11. 551
  12. 552
  13. 553
  14. 554
  15. 555
  16. 556
  17. 557
  18. 558
  19. 559

    Prevalence and factors associated with uptake of pre-exposure prophylaxis amongst women vulnerable to HIV who received HIV antibodies in Antibody Mediated Prevention HVTN703/HPTN081 trial in Harare, Zimbabwe: a cross-sectional study by Bernard Ngara, Bekezela Siziba, Nyaradzo Mavis Mgodi, Tariro Dianah Chawana, Miria Chitukuta, Pamela Grace Mukwekwerere, Muchaneta Bhondai-Mhuri, Zvavahera Mike Chirenje, Felix Godwin Sivukile Mhlanga

    Published 2024-04-01
    “…Introduction There is limited evidence on pre-exposure prophylaxis (PrEP) uptake post-trial participation for women vulnerable to HIV. This study investigates the prevalence and factors associated with PrEP uptake post-participation in an HIV prevention trial.Methods Former Antibody Mediated Prevention (AMP) study participants were invited to the three AMP clinical research sites in Zimbabwe after at least a year of exiting the study. …”
    Get full text
    Article
  20. 560